These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 950465

  • 1. C3 requirements for formation of alternative pathway C5 convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Aug; 117(2):630-4. PubMed ID: 950465
    [Abstract] [Full Text] [Related]

  • 2. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 3. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 4. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
    [Abstract] [Full Text] [Related]

  • 5. Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.
    Daha MR, Fearon DT, Austen KF.
    Immunology; 1976 Nov; 31(5):789-96. PubMed ID: 992711
    [Abstract] [Full Text] [Related]

  • 6. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 7. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T, Takata Y, Kozono H, Takeda J, Hong KS, Inoue K.
    J Immunol; 1988 Dec 01; 141(11):3895-901. PubMed ID: 3183384
    [Abstract] [Full Text] [Related]

  • 8. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT, Austen KF.
    J Immunol; 1975 Nov 01; 115(5):1357-61. PubMed ID: 809512
    [Abstract] [Full Text] [Related]

  • 9. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 10. The natural modulation of the amplification phase of complement activation.
    Fearon DT, Daha MR, Weiler JM, Austen KF.
    Transplant Rev; 1976 Feb 01; 32():12-25. PubMed ID: 62426
    [Abstract] [Full Text] [Related]

  • 11. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
    Rawal N, Pangburn MK.
    Mol Immunol; 2007 Feb 01; 44(6):1105-14. PubMed ID: 16979240
    [Abstract] [Full Text] [Related]

  • 12. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH, Abramovitz AS, Mayer MM.
    J Immunol; 1976 Sep 01; 117(3):830-4. PubMed ID: 956655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation.
    Vogt W, Schmidt G, Hinsch B.
    Immunology; 1979 Jan 01; 36(1):139-43. PubMed ID: 422225
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I, Sahu A, Friedman HM, Eisenberg RJ, Cohen GH, Lambris JD.
    J Immunol; 1997 Feb 15; 158(4):1763-71. PubMed ID: 9029114
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR, van Es LA.
    J Immunol; 1979 Mar 15; 122(3):801-5. PubMed ID: 448075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.